Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 24, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for April 26, 2008 Subscribe to this News Feed      
 

OxyContin and the FDA -- This Week on The Prescription Addiction Radio Show - Breaking the Silence - April 27 and May 4, WGUL 860 AM, Tampa, Florida

On May 5, 2008, the FDA is holding a hearing to discuss approving what Purdue Pharma claims is "a safer formulation" of OxyContin--"legal heroin" according to talk-show host Larry G. Larry Golbom, host of The Prescription Addiction Radio show, will be presenting information at the upcoming FDA hearing on May 5. On April 27 and May 4, Larry G will discuss his upcoming presentation on The Prescription Addiction Radio Show - Breaking the Silence on WGUL 860 AM, Tampa, Florida.

Tampa, Florida (PRWEB) April 26, 2008 -- On May 5, 2008, the FDA is holding a hearing to discuss approving what Purdue Pharma claims is "a safer formulation" of OxyContin--"legal heroin" according to talk-show host Larry G. Larry Golbom, host of The Prescription Addiction Radio show, will be presenting information at the upcoming FDA hearing on May 5. This Sunday night, April 27, and also on May 4 at 9 PM on WGUL 860 AM (streamed live on the internet at www.860wgul.com ), Larry G discusses what he states every police narcotics officer, addiction specialist and drug addict knows: "OxyContin is Interchangable with Heroin!"

Larry G states: "OxyContin-implicated deaths have become legendary in the beginning of our 21st century. The molecular similarity between the active ingredient of Oxycontin, oxycodone, and heroin is a fact. Every narcotics officer, DEA agent, addiction specialist and addict know that heroin and oxycodone are interchangeable and both cause lethal overdoses. The FDA has ignored this fact for years while thousands have died, thousands more have become addicted and countless families have suffered."

The introduction of OxyContin in 1995 has increased deaths and addictions from a legal drug not seen since the introduction of heroin as a 'safe' alternative to morphine over 100 years ago.
He continues, "The introduction of OxyContin in 1995 has increased deaths and addictions from a legal drug not seen since the introduction of heroin as a 'safe' alternative to morphine over 100 years ago." According to the FDA's own reporting system, the active ingredients of the new formulations accounted for the most deaths related to prescription drugs between 1998 and 2005.

In May of 2007 in a federal lawsuit brought against Purdue in Virginia by the Federal Government, Purdue Pharma, the manufacturer of OxyContin, its president, top lawyer and former chief medical officer admitted to criminal liability and agreed to pay $634.5 million in fines for claiming OxyContin was less addictive and less subject to abuse than other pain medications--claims that the company admitted were untrue when they made them.

On May 5, 2008, the FDA is holding a hearing to discuss approving what Purdue Pharma, claims is "a safer formulation" of OxyContin--"legal heroin", according to Larry G. "There are serious questions as to the validity of the information submitted by Purdue," says Larry Golbom in a letter to the FDA and about which Larry will be presenting information on May 5th at the FDA hearing.

The unrelenting talk show host says, "The FDA is on notice that Purdue Pharma made false claims that led to thousands of deaths and devastated lives. An approval by the FDA of Purdue's unproven claims will lead to even greater numbers of deaths and ruined lives because more doctors will mistakenly believe that it is safe to prescribe OxyContin."

Join The Prescription Addiction Radio Show - Breaking the Silence on Sunday, April 27th and on May 4th on WGUL 860 AM at 9 PM (streamed live on the internet at www.860wgul.com ) as Larry G discusses what he describes as the flaws and misrepresentations in Purdue Pharma's application to the FDA. Every medical professional, media person and family member fighting addiction from a prescription drug should be interested in these shows. Let the FDA know you are listening.

ABOUT THE PRESCRIPTION ADDICTION RADIO SHOW - BREAKING THE SILENCE:     http://www.prescriptionaddictionradio.com

Hosted by Larry G., a registered pharmacist for over 30 years, The Prescription Addiction Radio Show, sponsored by Novus Medical Detox (http://www.novusdetox.com), is dedicated to the thousands of families who are being or have been affected by the misuse of prescription drugs.

###

Post Comment:
Trackback URL: http://ca.prweb.com/pingpr.php/SW5zZS1JbnNlLVpldGEtTG92ZS1GYWx1LVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Steve Hayes
Novus Medical Detox
727-213-1741
Email us Here
Larry G
Prescription Addiction Radio
813-289-1860
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright